Starling Oncology Inc STLN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
-
Starling Oncology to Participate in Wells Fargo Healthcare Conference
-
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
-
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
-
The Oncology Institute Rebrands as Starling Oncology
-
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
Trading Information
- Previous Close Price
- $6.91
- Day Range
- $6.66–6.96
- 52-Week Range
- $2.32–7.13
- Bid/Ask
- $6.69 / $7.00
- Shares Outstanding
- 101.92M
- Market Cap
- $683.86M
- Volume/Avg
- 1M / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.15
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Core
- Total Number of Employees
- 641
- Website
- https://www.starlingoncology.com
Valuation
|
Metric
|
STLN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1.15 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
STLN
|
|---|---|
Quick Ratio | 1.14 |
Current Ratio | 1.36 |
Interest Coverage | −3.76 |
Quick Ratio
STLN
Profitability
|
Metric
|
STLN
|
|---|---|
Return on Assets (Normalized) | −16.63% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −22.80% |
Return on Assets
STLN
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Genesis Healthcare Inc Class A
GENNQ
| LOCK|N<! | LOCK|Wt | — | |||
| HCA Healthcare Inc
HCA
| LOCK|W##RYxt | LOCK|@K^c | $102B | |||
| Fresenius SE & Co KGaA Registered Shares
FSNUF
| — | LOCK|@<^s | $29B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | LOCK|Sj## | $29B | |||
| Tenet Healthcare Corp
THC
| LOCK|rxPH%qJ | LOCK|y!$?@ | $22B | |||
| Encompass Health Corp
EHC
| — | LOCK|M!lV | $12B | |||
| Fresenius Medical Care AG
FMCQF
| — | LOCK|<v%cs | $12B | |||
| Fresenius Medical Care AG ADR
FMS
| LOCK|WWNBs! | LOCK|x#^H! | $12B | |||
| DaVita Inc
DVA
| LOCK|J?qdlC? | LOCK|??@y> | $12B | |||
| Universal Health Services Inc Class B
UHS
| LOCK|w@c<!w> | LOCK|DPzdh | $11B |
United States